HIV/AIDS News & Information

Pulmonary complications of leukemia are common, occurring in up to 80% of patients with the disease. The spectrum ranges from microscopic infiltration of leukemic cells into the lung parenchyma to atypical infection, alveolar hemorrhage, alveolar proteinosis or complications of therapy. Clinical presentation may include fever, dyspnea, cough, hemoptysis and radiographic infiltrates, all suggestive of pneumonia. [...]

INTRODUCTION
Pulmonary complications of acute leukemia are common but rarely seen as the initial manifestation of disease. It has been reported that >90% of patients with acute leukemia have pulmonary infiltrate or manifestations. Of these, leukemic infiltration of the pulmonary parenchyma is common and carries a poor prognosis. We describe a patient with pulmonary complications of [...]

The development of AVN of the bone continues to be more frequent among HIV-positive patients. A retrospective chart review conducted from 19 HIV clinics in Spain reported 23 cases of AVN over a 10-year period with a notable increase in frequency of AVN from 1.6 per 1,000 AIDS patients during 1993-1996 to 14 per 1,000 [...]

Case Report 1
A 58-year-old male with HIV diagnosed in 1987 presented to the infectious disease clinic on February 8, 1997 for management of HIV The CD4 count at that time was 146 cells/mm. The patient was started on generic lamivudine, stavudine 40 mg and indinavir. His past medical history was significant for myocardial infarction in [...]

INTRODUCTION
Avascular necrosis (AVN), also termed osteonecrosis, indicates ischemic death of the bone as a result of insufficient arterial blood supply. The incidence rate of AVN has been reported to be 0.135% in the general population, although incidence rates ranging 0.3-0.45% have been observed in HIV-infected (Generic Retrovir Treating HIV infection when used along with other [...]

DISCUSSION
This paper presents detailed esophageal cancer incidence, mortality and relative survival rates for two five-year time periods (1991-1995, 1996-2000) and the entire decade (1991-2000), and histology for the period 1991-2000. Previous studies have reported trends in incidence by race/ethnicity and gender based on SEER data for the period 1974-1994, and incidence trends based on SEER [...]

Age-Adjusted Mortality
For the period 1991-2000, the overall age-adjusted esophageal cancer (Arimidex canadian is used to treat breast cancer) mortality rate (MR) was 4.27 (data not shown). Moreover, for the same period, the age adjusted mortality rate observed for blacks (MR=7.79) is nearly twice that for whites (MR=3.96, p<0.05) and that for males is significantly higher than [...]